Delineating the Durability Outcome Differences After Saphenous Ablation with Laser Versus Radiofrequency

Yoon, William; Drescher, Max; Crisostomo, Paul R.; Halandras, Pegge; Aulivola, Bernadette

doi:10.1016/j.jvs.2017.06.013

Cited by 3 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Laser and Radiofrequency Ablation (LARA) study conducted by Goode et al 17 in 2009 demonstrated that RFA and EVLA have equal 95% efficacy, with RFA causing less pain and bruising postoperatively. In 2019, Yoon et al 18 reported 343 limbs treated with EVLA or RFA and also found no statistically significant difference in clinical recurrence of reflux between the two groups. Although both of these studies focused on treatment of the GSV, other studies have demonstrated technical success with EVLA and RFA for the treatment of the AASV.…”

Section: Discussionmentioning

confidence: 99%

A single-center experience of anterior accessory saphenous vein endothermal ablation demonstrates safety and efficacy

Charitable

Speranza

Rockman

et al. 2022

Journal of Vascular Surgery: Venous and Lymphatic Disorders

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

A single-center experience of anterior accessory saphenous vein endothermal ablation demonstrates safety and efficacy

Charitable

Speranza

Rockman

et al. 2022

Journal of Vascular Surgery: Venous and Lymphatic Disorders

View full text Add to dashboard Cite

“…Owing to the development of endovenous interventions, the treatment strategy for varicose veins has changed in recent years. Surgical indications for treatment include symptomatic superficial venous insufficiency, CEAP clinical class ⩾ 2, and duration of reversed venous flow exceeding 0.5 s. 14 From January 2017 to December 2020, 1204 patients hospitalized at the Division of Vascular Surgery, Qingpu Branch of Zhongshan Hospital with signs and symptoms of varicose veins (CEAP clinical class ⩾ 2) were enrolled. Patients with previous surgical intervention were not included.…”

Section: Methodsmentioning

confidence: 99%

“…All patients received preoperative duplex ultrasonography to check the presence of reflux in deep and superficial veins and to exclude potential thrombosis. 15 The cut-off value of reflux in the superficial veins was defined as 500 ms. 14 The more severely affected limb was taken into consideration if patients had bilateral lesions. Patients meeting the following criteria were excluded: missing data, < 18 years of age, Klippel–Trenaunay syndrome, history of immune diseases, deep venous thrombosis, peripheral artery diseases (ankle–brachial index < 0.9), or iliac vein compression syndrome.…”

Section: Methodsmentioning

confidence: 99%

Elevated serum homocysteine levels are associated with the development of chronic venous ulcers

Guo

Wang

et al. 2022

Vasc Med

View full text Add to dashboard Cite

Introduction: Venous ulceration is a multifactorial disease, and whether hyperhomocysteinemia (HHcy) promotes deterioration from primary varicose veins to venous ulcers remains unproven. Methods: This study retrospectively analyzed clinical data from 717 patients to investigate the potential correlation between HHcy and primary varicose veins ulcer formation, including 611 patients without ulcers (control group) and 106 with ulcers (case group). Results: In this study, 46.2% (49/106) of patients in the case group and 17.5% (107/611, p < 0.001) in the control group suffered from HHcy. Multivariate logistic analysis revealed that HHcy was closely associated with the incidence of venous ulceration in patients with primary varicose veins ( p < 0.001). Propensity score matching created 101 matched pairs of patients with and without ulcers, and the analysis pointed to a potential link between HHcy and ulcer formation in the context of primary varicose veins ( p < 0.001). Additional experiments showed that HHcy could induce endothelial dysfunction and phenotypic switching of vascular smooth muscle cells. Conclusion: Both clinical and experimental findings implicated HHcy as a key factor in the development of venous ulceration. Further research is needed to appraise the effectiveness of HHcy-lowering therapy in the prevention of venous ulcers in patients with varicose veins.

show abstract

“…No difference was noted in QoL scores between the two groups at 6 months follow‐up 112 . Overall, several randomized trials have compared RFA with EVLA in terms of safety and efficacy 113–117 . RFA seemed to be at least as efficacious as EVLA in terms of clinical improvement and QoL scores; RFA was associated with less post‐procedural pain and bruising compared with EVLA 69,113,114,116,117 …”

Section: Interventional Treatment Of Superficial Venous Insufficiencymentioning

confidence: 99%

Treatment of chronic venous disorder: A comprehensive review

Chaitidis¹,

Kokkinidis

Papadopoulou

et al. 2021

Dermatologic Therapy

View full text Add to dashboard Cite

Chronic venous disorder (CVD) is highly prevalent vascular disorder affecting up to 45% of the general population, with clinical manifestations ranging from teleangiectasias to venous leg ulcers (VLUs). We examined the currently available data in order to provide an updated, comprehensive review on treatment options of CVD. We searched MEDLINE, Cochrane, Scopus, EMBASE, ClinicalTrials, and OpenGrey databases for relevant articles in English published until November 2020. Compression treatment is the mainstay of conservative treatment. Pharmacological treatment can provide significant symptomatic relief and hence it should be considered as part of conservative treatment. Transcutaneous Lacer treatment (TCL) is a safe and effective alternative option to sclerotherapy for treatment of C1 stage. High ligation and stripping (HL/S), ultrasound‐guided foam sclerotherapy (UGFS), endovenous thermal ablation (EVTA) systems and non thermal non tumescent ablation (NTNT) systems are safe and efficacious first‐line options for treatment of saphenous insufficiency. Interventional treatment of co‐existing incompetent perforator veins (IPVs) is not supported by contemporary evidence. Regarding deep venous insufficiency (DVI), treatment of symptomatic femoroiliocaval occlusive venous disease refractory to conservative treatment with percutaneous transluminal venoplasty stenting has produced encouraging results.

show abstract

Delineating the Durability Outcome Differences After Saphenous Ablation with Laser Versus Radiofrequency

Cited by 3 publications

References 0 publications

A single-center experience of anterior accessory saphenous vein endothermal ablation demonstrates safety and efficacy

A single-center experience of anterior accessory saphenous vein endothermal ablation demonstrates safety and efficacy

Elevated serum homocysteine levels are associated with the development of chronic venous ulcers

Treatment of chronic venous disorder: A comprehensive review

Contact Info

Product

Resources

About